Are there any recent updates on Mitsubishi Tanabe and dersimelagon (MT-7117). I try to keep a close eye on it since it is potentially our most serious competitor especially in light of what is going on with Disc Medicine. I read all of the scholarly publications involving it. Unfortunately there are not many forum discussions about it online. There may be a total of a few posts here or there I can find where people even mention it including this one. I don't want to discount it entirely since I am a risk averse person. I had originally thought some of the earlier MT-7117 studies looked very promising. Yet the overall sentiment of many seems to be pretty negative regarding it. Could the forum members please provide any details regarding what they know regarding the recent safety and efficacy of dersimelagon. I hear there are some potential problems. Thank you in advance.
MT 7117, page-9
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.90 |
Change
-0.200(1.42%) |
Mkt cap ! $695.8M | |||
| Open | High | Low | Value | Volume |
| $14.08 | $14.12 | $13.86 | $1.006M | 72.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 210 | $13.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.94 | 576 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |